User profiles for Leslie M. Thompson

Leslie M. Thompson

UC Irvine
Verified email at uci.edu
Cited by 30590

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

R Shiang, LM Thompson, YZ Zhu, DM Church… - Cell, 1994 - cell.com
Achondroplasia(ACH) is the most common genetic form of dwarfism. This disorder is inherited
as an autosomal dominant trait, although the majority of cases are sporadic. A gene for …

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila

…, DE Housman, GR Jackson, JL Marsh, LM Thompson - Nature, 2001 - nature.com
Proteins with expanded polyglutamine repeats cause Huntington's disease and other
neurodegenerative diseases. Transcriptional dysregulation and loss of function of transcriptional co…

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

…, DE Housman, LM Thompson - Proceedings of the …, 2000 - National Acad Sciences
Huntington's Disease (HD) is caused by an expansion of a polyglutamine tract within the
huntingtin (htt) protein. Pathogenesis in HD appears to include the cytoplasmic cleavage of htt …

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

…, JS Steffan, JL Marsh, LM Thompson… - Proceedings of the …, 2003 - National Acad Sciences
Huntington's disease (HD) is an inherited, progressive neurological disorder that is caused
by a CAG/polyglutamine repeat expansion and for which there is no effective therapy. Recent …

Therapeutic application of histone deacetylase inhibitors for central nervous system disorders

AG Kazantsev, LM Thompson - Nature reviews Drug discovery, 2008 - nature.com
Histone deacetylases (HDACs) — enzymes that affect the acetylation status of histones and
other important cellular proteins — have been recognized as potentially useful therapeutic …

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3

PL Tavormina, R Shiang, LM Thompson, YZ Zhu… - Nature …, 1995 - nature.com
Thanatophoric dysplasia (TD), the most common neonatal lethal skeletal dysplasia, affects
one out of 20,000 live births. Affected individuals display features similar to those seen in …

Green tea (−)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models

…, J Legleiter, JL Marsh, LM Thompson… - Human molecular …, 2006 - academic.oup.com
Huntington's disease (HD) is a progressive neurodegenerative disorder for which only
symptomatic treatments of limited effectiveness are available. Preventing early misfolding steps …

[PDF][PDF] The library of integrated network-based cellular signatures NIH program: system-level cataloging of human cells response to perturbations

…, MS Casale, TG Thompson, J Wu, LM Thompson… - Cell systems, 2018 - cell.com
The Library of Integrated Network-Based Cellular Signatures (LINCS) is an NIH Common
Fund program that catalogs how human cells globally respond to chemical, genetic, and …

SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis

…, GP Bates, C Neri, LM Thompson… - Proceedings of the …, 2010 - National Acad Sciences
Huntington’s disease (HD), an incurable neurodegenerative disorder, has a complex
pathogenesis including protein aggregation and the dysregulation of neuronal transcription and …

[HTML][HTML] Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease

…, C Cotman, GA Prieto, LM Thompson… - Nature …, 2020 - nature.com
The discovery of TREM2 as a myeloid-specific Alzheimer’s disease (AD) risk gene has
accelerated research into the role of microglia in AD. While TREM2 mouse models have provided …